Esperion still paying Zacks Equity Research for positive articles
- Thread starter anonymous
- Start date
-
- Tags
- None
A new article will be out shortly especially after the week Esperion just had. Amazing the investment houses don't out a fork in this debacle. Waste!
Any Esperion media nonsense will be published if they pay for it
Disgraceful business practice AZ after 3 years if the drug hasn't impacted it never will. The first 3-6 months are crucial in a launch. By Esperion hiring the wrong people and others who Tick Tocked their day away soon found out that the BS they shoveled in the Scientific Interviews was all a scam. The sales results stand for themself.
Disgraceful business practice AZ after 3 years if the drug hasn't impacted it never will. The first 3-6 months are crucial in a launch. By Esperion hiring the wrong people and others who Tick Tocked their day away soon found out that the BS they shoveled in the Scientific Interviews was all a scam. The sales results stand for themself.
Obviously you've never been involved in a successful launch. The first 3 months of a launch are crucial to the future success of a drug. The next 3 months afterwards are even more important. If the drug hasn't made a positive impact at this point it will never be a blockbuster. Historically this is when companies will pull the plug. Do your research. You can't use BA as an example as this failed miserably out of the gate. BA should never have been marketed after 2020.
Thanks, rep analyst. With your insights into what makes success in the pharmaceutical industry, why are you still picking up coffee and lunch?
You don’t know what you are talking about, moron.